Liposomal doxorubicin (TLC D99, myocet) in combination with cyclophosphamide (C), vincristine (O) and prednisone (P) for aggressive non-Hodgkin's lymphomas (NHL).

被引：0
|
作者：
Levine, A
Tulpule, A
Espina, B
Buchanan, L
Africano, M
Welles, L
机构：
[1] Univ So Calif, Norris Canc Hosp, Los Angeles, CA USA
[2] Med Res, Princeton, NJ USA
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
478P
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [1] Liposomal doxorubicin (TLC-D99) in combination with cyclophosphamide (C), vincristine (V), and prednisone (P) is active in newly diagnosed aggressive non-Hodgkin's lymphoma (NHL).
    Tulpule, A
    Espina, BM
    Berman, N
    Buchanan, LH
    Boswell, WD
    Welles, L
    Levine, AM
    BLOOD, 2001, 98 (11) : 346A - 346A
  • [2] Liposomal doxorubicin (TLC D-99), cyclophosphamide, oncovin and prednisone (COP) in the treatment of aggressive non-Hodgkin's lymphomas (NHL).
    Levine, AM
    Tulpule, A
    Espina, BM
    Buchanan, LH
    Africano, M
    Boswell, W
    Welles, L
    BLOOD, 2000, 96 (11) : 137A - 137A
  • [3] Treatment of relapsed non-Hodgkin's-lymphoma (NHL) with liposomal Daunoxome® in combination with cyclophosphamide, vincristine and prednisone (CDaXOP).
    Röhnisch, T
    Zippelius, A
    Vehling-Kaiser, U
    Hiller, E
    Dreyling, M
    Jung, C
    Oduncu, F
    Emmerich, B
    Hiddemann, W
    Hallek, M
    BLOOD, 1999, 94 (10) : 525A - 525A
  • [4] Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab for the treatment of non-Hodgkin's lymphoma: Study of 26 patients
    Moreno, Miriam
    Sancho, Juan-Manuel
    Gardella, Santiago
    Coll, Rosa
    Garcia, Olga
    Gallardo, David
    Ribera, Josep-Maria
    MEDICINA CLINICA, 2010, 134 (02): : 72 - 75
  • [5] Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide,vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma
    Tulpule, Anil
    Espina, Byron M.
    Berman, Nancy
    Buchanan, Laura H.
    Smith, D. Lynne
    Sherrod, Andy
    Dharmapala, Dharshika
    Gee, Conway
    Boswell, William D.
    Nathwani, Bharat N.
    Welles, Lauri
    Levine, Alexandra M.
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (01): : 59 - 64
  • [6] Liposomal doxorubicin in combination with vincristine, cyclophosphamide and prednisone in patients with aggressive diffuse large B-cell lymphomas (DLBCL)
    Stulginskaya, Marina A.
    Dudnichenko, Alexander S.
    ANNALS OF ONCOLOGY, 2004, 15 : 155 - 156
  • [7] Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma
    R. I. Fisher
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S42 - S46
  • [8] TREATMENT OF DIFFUSE HISTIOCYTIC AND DIFFUSE MIXED NON-HODGKIN LYMPHOMAS WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP)
    COHEN, Y
    EPELBAUM, R
    BENSHAHAR, M
    RON, Y
    HAIM, N
    ACTA ONCOLOGICA, 1988, 27 (05) : 531 - 535
  • [9] Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma
    Fisher, RI
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S42 - S46
  • [10] Efficacy of cyclophosphamide, doxorubicin, etoposide and prednisone (CHEP) chemotherapy in previously untreated aggressive non-Hodgkin's lymphoma (NHL).
    Lee, WS
    Joo, YD
    Chung, JS
    Cho, GJ
    Park, KT
    Sohn, CH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 614S - 614S
12345